The European Medicines Agency (EMA) has informed Wockhardt that WCK 5222 (combination of Zidebactam 1g + Cefepime 2g) is eligible for Accelerated Assessment, following a pre-submission meeting with ...

Mumbai: Wockhardt has announced that it has been informed by the European Medicines Agency (EMA) that WCK 5222, a combination ...

New French guidelines reshape care for urinary tract infections in men, dropping urine dipsticks, recognizing male cystitis, and clarifying antibiotic choices and treatment durations.

GSK has resubmitted its NDA to the FDA for tebipenem HBr, an oral carbapenem for complicated UTIs, backed by positive phase 3 ...

Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial ...

UTI (Urinary tract infection) is and infection of the urinary tract, usually caused by bacteria. Urinary tract consists of 3 ...

Spero Therapeutics ( ($SPRO) ) has provided an update. On December 19, 2025, Spero Therapeutics reported that its partner GlaxoSmithKline ...

Urinary tract infections (UTIs) are increasingly common in men, especially with age, posing serious health risks like blood infections and frequent re ...

In a significant stride towards advancing treatment options for complicated urinary tract infections (cUTIs), GSK has resubmitted a New Drug Application (NDA) to the FDA for tebipenem pivoxil ...